Table 1.

Preoperative Demographics and Clinical Status

AllHeartMate IIHVAD
PatientsGroupGroup
Variablen=184n=161n=23P-Value
Age, years, mean ± SD51.6 ± 12.351.6 ± 12.451.2 ± 11.80.89
Male, n (%)133 (72)119 (74)14 (61)0.22
Body mass index, kg/m2, mean ± SD28.8 ± 5.228.6 ± 5.030.1 ± 6.40.20
Indication, n (%)0.04
 Bridge to transplant90 (49)74 (46)16 (70)
 Destination therapy94 (51)87 (54)7 (30)
INTERMACS profile, n (%)0.56
 115 (8)15 (9)0
 2154 (84)132 (82)22 (96)
 311 (6)10 (6)1 (4)
 43 (2)3 (2)0
 51 (1)1 (1)0
NYHA class, n (%)0.50
 II10 (5)10 (6)0
 III25 (14)23 (14)2 (9)
 IV149 (81)128 (80)21 (91)
Hemodynamics
 Cardiac index, L/m2, mean ± SD1.93 ± 0.631.93 ± 0.651.94 ± 0.520.96
 Heart rate, bpm, mean ± SD92.1 ± 16.292.1 ± 16.491.7 ± 15.30.91
 CVP, mmHg, mean ± SD9.2 ± 5.29.2 ± 5.28.2 ± 4.40.46
 PCWP, mmHg, mean ± SD23.2 ± 8.723.0 ± 8.324.5 ± 10.80.50
 LVEF, %, mean ± SD15.5 ± 5.415.5 ± 5.515.9 ± 5.10.74
Preimplant MCS, n (%)33 (18)29 (18)4 (17)1.00
Intra-aortic balloon pump, n (%)142 (77)123 (76)19 (83)0.61
History, n (%)
 Diabetes79 (43)68 (42)11 (48)0.66
 Dyslipidemia84 (46)75 (47)9 (39)0.66
 Hypertension129 (70)111 (69)18 (78)0.47
 COPD44 (24)38 (24)6 (26)0.80
 Stroke22 (12)20 (12)2 (9)1.00
Laboratory
 INR, mean ± SD1.17 ± 0.311.19 ± 0.321.04 ± 0.090.03
 Total bilirubin, mg/dL, mean ± SD1.10 ± 0.711.11 ± 0.721.04 ± 0.650.64
 Creatinine, mg/dL, mean ± SD1.26 ± 0.621.25 ± 0.641.31 ± 0.420.67
 BUN, mg/dL, mean ± SD25.7 ± 15.429.6 ± 16.825.1 ± 15.10.25
MELD score11.0 ± 4.411.1 ± 4.610.2 ± 3.10.35
  • BUN, blood urea nitrogen; COPD, chronic obstructive pulmonary disease; CVP, central venous pressure; HVAD, HeartWare ventricular assist device; INR, international normalized ratio; INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support; LVEF, left ventricular ejection fraction; MCS, mechanical circulatory support; MELD, Model for End-Stage Liver Disease; NYHA, New York Heart Association; PCWP, pulmonary capillary wedge pressure.